Radiation treatment "suicide gene therapy" has proved successful in targeting prostate cancer, clinical trials have shown.Read the full story ›
A woman who was diagnosed with an aggressive form of breast cancer when 13 weeks pregnant is due to have her baby prematurely.Read the full story ›
Surgeon Mr James Arbuckle explains on the Tonight programme how you can watch for the early signs of bowel cancerRead the full story ›
A World Health Organisation report suggested eating processed meat can cause cancer. The Tonight programme examines the science.Read the full story ›
Older people are less likely to get life-saving cancer care than younger people but this doesn't mean they don't want it, a charity warns.Read the full story ›
NHS patients in England will get results for cancer tests within four weeks of being referred by a GP, under new plans.Read the full story ›
18-year-old Charlotte Eades was diagnosed with cancer at just 16. She's released a powerful video documenting her struggles.Read the full story ›
A combination of cancer drugs that can shrink skin cancer tumours in more than half of patients may not be cost-effective for the NHS to supply patients.
A British-led trial has found immune-boosting drugs - ipilimumab and nivolumab - stopped advanced melonoma for nearly a year in 58% of cases.
But the high success rate comes with a high price tag, as ITV News' Health Editor Rachel Younger reports:
How much patients benefit from the new immuno-therapy treatment announced today in the fight against cancer will depend on which drugs suit them best, according to a leading expert.
Speaking to ITV News, Dr Alan Worsley of Cancer Research UK said that patients might respond best to one type of drug or a combination of therapies.
Discovery of an immuno-based therapy has been hailed as a breakthrough in the fight against cancer. We look at other major developmentsRead the full story ›